Biopharmaceutical CMO And CRO Market Share

Statistics for the 2023 & 2024 Biopharmaceutical CMO And CRO market share, created by Mordor Intelligence™ Industry Reports. Biopharmaceutical CMO And CRO share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Biopharmaceutical CMO And CRO Industry

The biopharmaceutical CMO and CRO market is moderately competitive and consists of several significant players. In terms of market share, a few major players dominate the market. Some prominent players are vigorously making acquisitions of other companies to consolidate their global market positions. Some of the major market players are Lonza Group AG, ICON PLC, Parexel International Corporation, Samsung Biologics, and Charles River Laboratories International Inc.

Biopharmaceutical CMO And CRO Market Leaders

  1. Lonza Group AG

  2. ICON Plc

  3. Parexel International Corporation

  4. Samsung Biologics

  5. Charles River Laboratories International, Inc.

*Disclaimer: Major Players sorted in no particular order

Biopharmaceutical CMO And CRO Market Concentration

Biopharmaceutical CMO and CRO Market Size & Share Analysis - Growth Trends and Forecasts (2024 - 2029)